Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label HELIOS Trial Data for AMX0035 in The Journal of Clinical Investigation | AMLX Stock News

Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label HELIOS Trial Data for AMX0035 in The Journal of Clinical Investigation | AMLX Stock News

StockTitan

May 15, 2026 at 03:15 AM

Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label HELIOS Trial Data for AMX0035 in The Journal of Clinical Investigation | AMLX Stock News

Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label HELIOS Trial Data for AMX0035 in The Journal of Clinical Investigation | AMLX Stock News

Login to unlock169characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Amylyx Pharmaceuticals

USAMLX

-2.12%

Direxion S&P Biotech Bull 3X

USLABU

iShares US Pharma

USIHE

LongbridgeAI